Von Willebrand's disease.
D000818:Animals; D000941:Antigens / Q000032:analysis; D001760:Bleeding Time; D001792:Blood Platelets / Q000032:analysis / Q000378:metabolism; D001803:Blood Transfusion; D002417:Cattle; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003894:Deamino Arginine Vasopressin; D004195:Disease Models, Animal; D004727:Endothelium / Q000032:analysis / Q000378:metabolism; D005169:Factor VIII / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D005340:Fibrinogen / Q000627:therapeutic use; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D008533:Megakaryocytes / Q000032:analysis / Q000378:metabolism; D010973:Platelet Adhesiveness; D011817:Rabbits; D013552:Swine; D014842:von Willebrand Diseases / Q000097:blood* / Q000235:genetics / Q000628:therapy; D014841:von Willebrand Factor / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics
D000941:Antigens; D006023:Glycoproteins; C026912:cryoprecipitate coagulum; D014841:von Willebrand Factor; D005169:Factor VIII; D005340:Fibrinogen; D003894:Deamino Arginine Vasopressin